Major
citalopram × Ketoconazole
SSRI (selective serotonin reuptake inhibitor)×Systemic antimycotics. Imidazole derivatives
Mechanism
Ketoconazole is a potent CYP3A4 inhibitor. Effect on citalopram is moderate (CYP3A4 is a minor route), but ketoconazole itself prolongs QT, so additive torsades de pointes risk persists.
Symptoms
QT prolongation on ECG. Clinically: dizziness, syncope, palpitations. Severe cases progress to polymorphic ventricular tachycardia (torsades de pointes). Risk is higher with hypokalaemia, hypomagnesaemia, bradycardia, and ischaemic heart disease.
Management
Avoid the combination. Alternative antifungals: terbinafine for dermatophytosis or echinocandins for systemic mycoses. If ketoconazole is needed: ECG before start and at day 3 of therapy.